ESPL1 and gastric cancer: Interestingly, we also found that ESPL1 protein level was significantly elevated in GC patients with pathological grade III (IRS, 5.48 ± 2.55) compared with that in patients of pathological grade II (IRS, 3.88 ± 2.22) (P < 0.05) (Fig. 4c).